Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2024-07-23 08:49:39

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

WAEH Newsletter 🌍

WAEH 18th Annual Meeting Call for Abstracts open now! The 18th annual meeting of the WAEH is getting closer and closer! From November 7 to 12, we will visit AIER […]

News from our member L V Prasad Eye Institute

Monthly Note: Green LVPEI June is a very special month at LVPEI. 37 years ago, on June 1, we formally launched the organization by starting our patient services. Beginning from […]

News from the Jerome Jacobson International Program at the Kellogg Eye Center: Major Bequest Supports Kellogg Collaboration With Kisii Eye Hospital in Kenya

News from our member Kellogg Eye Center A $60,000 anonymous bequest has been made to support the Kellogg partnership with the Kisii Eye Hospital in rural Kenya. It will extend […]

News from the Jerome Jacobson International Program at the Kellogg Eye Center: Michelle Sun, MD, MPH Completes Kellogg Global Fellowship

News from our member Kellogg Eye Center Michelle Sun, MD, MPH will come to the end of her 1-year fellowship in global ophthalmology at Kellogg in July 2024. The third […]

News from the Jerome Jacobson International Program at the Kellogg Eye Center: Ghanaian Pediatric Ophthalmologist Finishes Her Training With Observership At Kellogg

Vera Beyuo, MD (left) with Lianqun Wu, MD, a visiting pediatric ophthalmologist from China (center), and Otana Jakpor, MD, pediatric ophthalmology fellow at Kellogg. News from our member Kellogg Eye […]